<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ACON
Aclarion
$
()


  • Aclarion's Nociscan solution to be utilized in LIFEHAB trial

    4/25/2024 - 09:17am
  • Aclarion announces publication of peer-reviewed data in journal on lumbar discs

    3/4/2024 - 08:15am
  • Aclarion prices 5.175M units at 58c in public offering

    2/26/2024 - 09:19am
  • Aclarion plans to launch CLARITY trial, provides update on Alphatec partnership

    2/5/2024 - 08:09am
  • Aclarion files to sell 2.5M shares of common stock for holders

    1/22/2024 - 16:50pm
  • Aclarion expands Nociscan access into Phoenix with surgeon advisor Uribe

    1/22/2024 - 08:08am
  • Aclarion announces updated product release of Nociscan 2.6

    1/17/2024 - 08:07am
  • Aclarion, ATEC execute strategic partnership agreement

    1/8/2024 - 08:16am
  • Aclarion Inc trading halted, news pending

    1/3/2024 - 19:50pm
  • Aclarion announces 1-for-16 reverse stock split

    1/2/2024 - 12:02pm
  • Aclarion files to sell 25.93M units

    12/11/2023 - 16:58pm
  • Aclarion announces commercial milestone with completion of 1,000 nociscan exams

    11/27/2023 - 08:08am
  • Aclarion announces it enrolled ten KOLs to assist with Nociscan

    11/8/2023 - 08:09am
  • Aclarion expands immediate Nociscan access with KOL surgeon advisor addition

    11/6/2023 - 08:34am
  • Aclarion announces signing of commercial agreement with Porter Hospital

    10/25/2023 - 08:33am
dynamic_feed Breaking News